Lupin Limited
LUPIN
Rang in Aktien
#2107
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Aktienkurs
$21.43
Marktkapitalisierung
$9.80B
Veränderung (1 Tag)
0.14%
Veränderung (1 Jahr)
-2.88%
Land
IN
Handel Lupin Limited (LUPIN)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Lupin Limited (LUPIN)
Anzahl der ausstehenden Aktien zum June 2026: 457.19M
Laut den neuesten Finanzberichten und dem Aktienkurs von Lupin Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 457.19M. Am Ende von March 2024 hatte das Unternehmen 457.24M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Lupin Limited (LUPIN) von 2004 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 457.19M | -0.12% |
| 2025 | 457.75M | 0.11% |
| 2024 | 457.24M | 0.04% |
| 2023 | 457.05M | 0.66% |
| 2022 | 454.04M | -0.27% |
| 2021 | 455.29M | 0.57% |
| 2020 | 452.71M | 0.10% |
| 2019 | 452.25M | -0.29% |
| 2018 | 453.54M | 0.13% |
| 2017 | 452.97M | 0.10% |
| 2016 | 452.51M | 0.17% |
| 2015 | 451.74M | 0.00% |
| 2014 | 451.74M | 0.58% |
| 2013 | 449.13M | 0.60% |
| 2012 | 446.46M | 0.20% |
| 2011 | 445.58M | 3.52% |
| 2010 | 430.42M | 4.42% |
| 2009 | 412.21M | 0.99% |
| 2008 | 408.17M | 1.65% |
| 2007 | 401.54M | 0.03% |
| 2006 | 401.41M | 0.00% |
| 2005 | 401.41M | 0.00% |
| 2004 | 401.41M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 424.80% |
IN
|
